Literature DB >> 16454636

Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.

Alison B Clode1, Jennifer L Davis, Jacklyn Salmon, Tammy Miller Michau, Brian C Gilger.   

Abstract

OBJECTIVE: To determine penetration of topically and orally administered voriconazole into ocular tissues and evaluate concentrations of the drug in blood and signs of toxicosis after topical application in horses. ANIMALS: 11 healthy adult horses. PROCEDURE: Each eye in 6 horses was treated with a single concentration (0.5%, 1.0%, or 3.0%) of a topically administered voriconazole solution every 4 hours for 7 doses. Anterior chamber paracentesis was performed and plasma samples were collected after application of the final dose. Voriconazole concentrations in aqueous humor (AH) and plasma were measured via high-performance liquid chromatography. Five horses received a single orally administered dose of voriconazole (4 mg/kg); anterior chamber paracentesis was performed, and voriconazole concentrations in AH were measured.
RESULTS: Mean +/- SD voriconazole concentrations in AH after topical administration of 0.5%, 1.0%, and 3.0% solutions (n = 4 eyes for each concentration) were 1.43 +/- 0.37 microg/mL, 2.35 +/- 0.78 microg/mL, and 2.40 +/- 0.29 microg/mL, respectively. The 1.0% and 3.0% solutions resulted in significantly higher AH concentrations than the 0.5% solution, and only the 3.0% solution induced signs of ocular toxicosis. Voriconazole was detected in the plasma for 1 hour after the final topically administered dose of all solutions. Mean +/- SD voriconazole concentration in AH after a single orally administered dose was 0.86 +/- 0.22 microg/mL. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that voriconazole effectively penetrated the cornea in clinically normal eyes and reached detectable concentrations in the AH after topical administration. The drug also penetrated noninflamed equine eyes after oral administration. Low plasma concentrations of voriconazole were detected after topical administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454636     DOI: 10.2460/ajvr.67.2.296

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  12 in total

1.  Prospective open-label study of the administration of two-percent voriconazole eye drops.

Authors:  Daoud Al-Badriyeh; Lok Leung; Trent Roydhouse; Robert Fullinfaw; Mark Daniell; Geoffrey E Davies; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

2.  Diagnostic ophthalmology.

Authors:  Lynne S Sandmeyer; Bianca S Bauer; Kate Robinson; Bruce H Grahn
Journal:  Can Vet J       Date:  2014-03       Impact factor: 1.008

Review 3.  Optimal management of equine keratomycosis.

Authors:  Paula D Galera; Dennis E Brooks
Journal:  Vet Med (Auckl)       Date:  2012-03-12

4.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

5.  Aqueous humor concentration of voriconazole after topical administration in rabbits.

Authors:  Christian K Vorwerk; F Streit; L Binder; S Tuchen; C Knop; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-20       Impact factor: 3.117

6.  Equine keratomycoses in California from 1987 to 2010 (47 cases).

Authors:  Z Reed; S M Thomasy; K L Good; D J Maggs; K G Magdesian; N Pusterla; S R Hollingsworth
Journal:  Equine Vet J       Date:  2012-09-04       Impact factor: 2.888

7.  Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.

Authors:  Biswaranjan Mohanty; Sagar Kumar Mishra; Dipak K Majumdar
Journal:  J Adv Pharm Technol Res       Date:  2013-10

8.  Equine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles.

Authors:  Minna P Mustikka; Thomas S C Grönthal; Elina M Pietilä
Journal:  Vet Ophthalmol       Date:  2019-07-31       Impact factor: 1.644

9.  Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies.

Authors:  Mariano Mora-Pereira; Eva M Abarca; Sue Duran; William Ravis; Richard J McMullen; Britta M Fischer; Yann-Huei Phillip Lee; Anne A Wooldridge
Journal:  BMC Vet Res       Date:  2020-04-16       Impact factor: 2.741

10.  Use of autologous fascia lata graft to repair a complex corneal ulcer in a mare.

Authors:  Marcos Lores; Peter Rakestraw; Mieke De Rijck; Thomas Yarbrough
Journal:  Ir Vet J       Date:  2020-05-05       Impact factor: 2.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.